Which patients with ischemic stroke and insulin resistance may benefit from pioglitazone hydrochloride?

Graeme J. Hankey

doi:10.1001/jamaneurol.2017.2142

Which patients with ischemic stroke and insulin resistance may benefit from pioglitazone hydrochloride?

Graeme J. Hankey

UWA Medical School

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1294-1296
Number of pages	3
Journal	JAMA Neurology
Volume	74
Issue number	11
DOIs	https://doi.org/10.1001/jamaneurol.2017.2142
Publication status	Published - 1 Nov 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamaneurol.2017.2142

Cite this

@article{d44340ef557a4246933aa158c327feec,

title = "Which patients with ischemic stroke and insulin resistance may benefit from pioglitazone hydrochloride?",

author = "Hankey, \{Graeme J.\}",

year = "2017",

month = nov,

day = "1",

doi = "10.1001/jamaneurol.2017.2142",

language = "English",

volume = "74",

pages = "1294--1296",

journal = "JAMA Neurology",

issn = "2168-6149",